Testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy

Alexa Fortier; Seif Mokadem; Emlyn Cornet; Jean-Nicolas Cornu; Jean-Christophe Sabourin; Christian Pfister

doi:10.1016/j.eucr.2022.102055

Testicular recurrence of oligometastatic prostatic adenocarcinoma after 22 years of androgen deprivation therapy

Urol Case Rep. 2022 Mar 17:43:102055. doi: 10.1016/j.eucr.2022.102055. eCollection 2022 Jul.

Authors

Alexa Fortier¹, Seif Mokadem¹, Emlyn Cornet², Jean-Nicolas Cornu¹, Jean-Christophe Sabourin², Christian Pfister¹

Affiliations

¹ Urology Department, Rouen University Hospital, 1 Rue de Germont, 76031, Rouen Cedex, France.
² Department of Anatomopathology, Rouen University Hospital, 1 Rue de Germont, 76031, Rouen Cedex, France.

Abstract

Testicular metastasis of carcinoma is a rare condition. We report a rare case of right testicular metastasis of prostatic adenocarcinoma in an 84 years old patient, after more than 20 years of controlled disease under androgen deprivation therapy. Follow-up consisted in PSA monitoring, clinical examination, CT and bone scan. Biological recurrence, right testicular mass and finally right total orchiectomy allowed the diagnosis of a right testicular metastasis. PSA monitoring and clinical surveillance are important tools for diagnosing metastatic localisations.

Keywords: Metastasis; Orchiectomy; Prostate cancer; Testis.

Publication types

Case Reports